Preliminary Final Report
Filed with ASX · · 18 pages · English
Anatara Lifesciences Ltd on 6ix
Earlier from Anatara Lifesciences
- ANR and Zoetis to negotiate International Detach Commercial
- Investor Update and R&D Tax Rebate
- Zoetis Second Payment is received
- Investor Update
- R&D Tax Refund
Later from Anatara Lifesciences
- Pork CRC Options extended by 12 Months
- R&D Tax Incentive Received
- FDA approves the Human Food Safety Dossier
- Exclusive Global License Agreement with Zoetis
- Anatara CEO announces retirement
Follow Anatara Lifesciences into a list and get an email when it puts out news.
Follow Anatara Lifesciences